Skip to main content
SpringerLink
Log in

Women and Coronary Artery Disease

  • Chapter
Preventive Cardiology

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 134 Accesses

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality among women in the United States—500,000 women each year die of coronary heart disease (CHD). CHD is more age dependent in women than in men: women are usually 10 yr older than men when coronary manifestations first appear and MI may occur as much as 20 yr later. One in eight women aged 45–64 yr has clinical evidence of CHD and this increase to nearly 1 in 3 in women older than 65. With the aging of the American population, more women than men now die each year of CHD (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heart and Stroke Statistical Update. Dallas,TX, American Heart Association, 1996.

    Google Scholar 

  2. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women [see comments]. N Engl J Med 1993; 329: 247–256.

    Article  PubMed  CAS  Google Scholar 

  3. Barrett-Connor E. Heart disease in women. Fertil Steril 1994; 62: 127S–132S.

    PubMed  CAS  Google Scholar 

  4. Pashkow FJ. The Mona Lisa smiles: impact of risk factors for coronary artery disease in women [editorial; comment]. Cleve Clin J Med 1993; 60: 411–414.

    PubMed  CAS  Google Scholar 

  5. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women [see comments]. JAMA 1991; 265: 1861–1867.

    Article  PubMed  CAS  Google Scholar 

  6. Barrett-Connor E. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study. Ann Epidemiol 1992; 2: 77–83.

    Article  PubMed  CAS  Google Scholar 

  7. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114: 413–419.

    Article  PubMed  CAS  Google Scholar 

  8. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36–69.

    Article  Google Scholar 

  9. Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease [see comments]. N Engl J Med 1989; 321: 641–646.

    Article  PubMed  CAS  Google Scholar 

  10. Castelli WP, Doyle JT, Gordon T. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977; 55: 767–772.

    Article  PubMed  CAS  Google Scholar 

  11. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–714.

    Article  PubMed  CAS  Google Scholar 

  12. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. [Review]. Ann Inter Med 1979; 90: 85–91.

    CAS  Google Scholar 

  13. Jacobs D Jr, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32–47.

    PubMed  Google Scholar 

  14. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 1988; 34.

    Google Scholar 

  15. White AD, Hames CG, Tyroler HA. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol 1992; 2: 85–91.

    Article  PubMed  CAS  Google Scholar 

  16. Knapp RG, Sutherland SE, Keil JE, et al. A comparison of the effects of cholesterol on CHD mortality in black and white women: twenty-eight years of follow-up in the Charleston Heart Study. J Clin Epidemiol 1992; 45: 1119–1129.

    Article  PubMed  CAS  Google Scholar 

  17. Manolio TA, Pearson TA, Wenger NK, et al. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol 1992; 2: 161–176.

    Article  PubMed  CAS  Google Scholar 

  18. Brunner D, Weisbort J, Meshulam N, et al. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo–Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol 1987; 59: 1271–1276.

    Article  PubMed  CAS  Google Scholar 

  19. Rifkind BM, Tamir I, Heiss G, et al. Distribution of high density and other lipoproteins in selected LRC prevalence study populations: a brief survey. Lipids 1979; 14: 105–112.

    Article  PubMed  CAS  Google Scholar 

  20. Khoo JC, Miller E, McLoughlin P, et al. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res 1990; 31: 645–652.

    PubMed  CAS  Google Scholar 

  21. Van Tol A. Reverse cholesterol transport. In: Steinmetz A, Kaffarnik H, Schneider J, eds. Cholesterol Transport Systems and Their Relation to Atherosclerosis. Springer-Verlag, New York, 1989, pp. 85–91.

    Chapter  Google Scholar 

  22. Miller NE, Hammett F, Saltissi S, et al. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) 1981; 282: 1741–1744.

    Article  CAS  Google Scholar 

  23. Ballantyne FC, Clark RS, Simpson HS, et al. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982; 31: 433–437.

    Article  PubMed  CAS  Google Scholar 

  24. Williams PT, Vranizan KM, Austin MA, et al. Familial correlations of HDL subclasses based on gradient gel electrophoresis. Arterioscler Thromb 1992; 12: 1467–1474.

    Article  PubMed  CAS  Google Scholar 

  25. Ohta T, Hattori S, Nishiyama S, et al. Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in normolipidemic males and females. J Lipid Res 1988; 29: 721–728.

    PubMed  CAS  Google Scholar 

  26. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990; 12: 321–331.

    Article  PubMed  CAS  Google Scholar 

  27. Desoye G, Schweditsch MO, Pfeiffer KP, et al. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 1987; 64: 704–712.

    Article  PubMed  CAS  Google Scholar 

  28. Stensvold I, Urdal P, Thurmer H, et al. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J 1992; 13: 1155–1163.

    PubMed  CAS  Google Scholar 

  29. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8–15.

    Article  PubMed  CAS  Google Scholar 

  30. Kannel WB. New perspectives on cardiovascular risk factors. Am Heart J 1987; 114: 213–219.

    Article  PubMed  CAS  Google Scholar 

  31. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995; 155: 57–61.

    Article  PubMed  CAS  Google Scholar 

  32. Bass KM, Newschaffer CJ, Klag MJ, et al. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993; 153: 2209–2216.

    Article  PubMed  CAS  Google Scholar 

  33. Hong MK, Romm PA, Reagan K, et al. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol 1991; 68: 1646–1650.

    Article  PubMed  CAS  Google Scholar 

  34. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015–3023.

    Article  Google Scholar 

  35. Kannel WB. Nutrition and the occurrence and prevention of cardiovascular disease in the elderly. Nutrit Rev 1988; 46: 68–78.

    Article  PubMed  CAS  Google Scholar 

  36. Campos H, McNamara JR, Wilson PW, et al. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988; 67: 30–35.

    Article  PubMed  CAS  Google Scholar 

  37. DeGraaf J, Hak LH, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306.

    Article  CAS  Google Scholar 

  38. Williams PT, Krauss RM, Vranizan KM, et al. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler Thromb 1992; 12: 332–340.

    Article  PubMed  CAS  Google Scholar 

  39. Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917–1921.

    Article  PubMed  CAS  Google Scholar 

  40. Slack J. Genetic influences on coronary heart disease in young women. In: Oliver M, ed. Coronary Heart Disease in Young Women. Churchill-Livingstone, Edinburgh, 1978, pp. 24–25.

    Google Scholar 

  41. Wagner JD, Clarkson TB, St CR, et al. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 1991; 88: 1995–2002.

    Article  PubMed  CAS  Google Scholar 

  42. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904–910.

    Article  PubMed  CAS  Google Scholar 

  43. Scanu AM. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. [Review]. Arch Pathol Lab Med 1988; 112: 1045–1047.

    PubMed  CAS  Google Scholar 

  44. Genest JJ, Jenner JL, McNamara JR, et al. Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease. Am J Cardiol 1991; 67: 1039–1145.

    Article  PubMed  Google Scholar 

  45. Bostom AG, Gagnon DR, Cupples LA, et al. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994; 90: 1688–1695.

    Article  PubMed  CAS  Google Scholar 

  46. Maeda S, Abe A, Seishima M, et al. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989; 78: 145–150.

    Article  PubMed  CAS  Google Scholar 

  47. Steinmetz J, Tarallo P, Fournier B, et al. Reference values of lipoprotein(a) in a French population. Presse Med 1994; 23: 1695–1698.

    PubMed  CAS  Google Scholar 

  48. Solymoss BC, Marcil M, Wesolowska E, et al. Relation of coronary artery disease in women 60 years of age to the combined elevation of serum lipoprotein(a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol 1993; 72: 1215–1219.

    Article  PubMed  CAS  Google Scholar 

  49. Kuchinskiene Z, Carlson LA. Composition, concentration, and size of low density lipoproteins and of sub-fractions of very low density lipoproteins from serum of normal men and women. J Lipid Res 1982; 23: 762–769.

    PubMed  CAS  Google Scholar 

  50. Walden CE, Knopp RH, Wahl PW, et al. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984; 311: 953–959.

    Article  PubMed  CAS  Google Scholar 

  51. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983; 118: 489–496.

    PubMed  CAS  Google Scholar 

  52. Schernthaner G, Kostner GM, Dieplinger H, et al. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 1983; 49: 277–293.

    Article  PubMed  CAS  Google Scholar 

  53. Cruickshanks KJ, Orchard TJ, Becker DJ. The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care 1985; 8: 118–124.

    Article  PubMed  CAS  Google Scholar 

  54. Laakso M, Barrett CE. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 1989; 9: 665–672.

    Article  PubMed  CAS  Google Scholar 

  55. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035–2038.

    Article  PubMed  CAS  Google Scholar 

  56. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. [Review]. Diabetes Care 1991; 14: 839–855.

    Google Scholar 

  57. Knopp RH, Van AM, McNeely M, et al. Effect of insulin-dependent diabetes on plasma lipoproteins in diabetic pregnancy. J Reprod Med 1993; 38: 703–710.

    PubMed  CAS  Google Scholar 

  58. Anonymous: National Center for Health Statistics: Plan and Operation of the Second National Health and Nurtition Examination Survey, 1976–1980. Washington, DC, US Government Printing Office, 1981.

    Google Scholar 

  59. Patterson CC, McCrum E, McMaster D. Factors influencing total cholesterol and high-density lipoprotein cholesterol concentrations in a population at high coronary risk. Acta Medica Scand 1988; 728 (Suppl): 150–158.

    CAS  Google Scholar 

  60. Wing RR, Bunker CH, Kuller LH, et al. Insulin, body mass index, and cardiovascular risk factors in premenopausal women. Arteriosclerosis 1989; 9: 479–484.

    Article  PubMed  CAS  Google Scholar 

  61. Van Horn LV, Ballew C, Liu K, et al. Diet, body size, and plasma lipids-lipoproteins in young adults: differences by race and sex. The Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Epidemiol 1991; 133: 9–23.

    PubMed  Google Scholar 

  62. Glueck CJ, Taylor HL, Jacobs D, et al. Plasma high-density lipoprotein cholesterol: association with measurements of body mass. The Lipid Research Clinics Program Prevalence Study. Circulation 1980.

    Google Scholar 

  63. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.

    Article  PubMed  CAS  Google Scholar 

  64. Despres JP, Allard C, Tremblay A, et al. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985; 34: 967–973.

    Article  PubMed  CAS  Google Scholar 

  65. Soler JT, Folsom AR, Kushi LH, et al. Association of body fat distribution with plasma lipids, lipoproteins, apolipoproteins AI and B in postmenopausal women. J Clin Epidemiol 1988; 41: 1075–1081.

    Article  PubMed  CAS  Google Scholar 

  66. Dustan HP. Coronary artery disease in women. Can J Cardiol 1990; 6: 19B–21B.

    PubMed  Google Scholar 

  67. Krauss RM. The tangled web of coronary risk factors. Am J Med 1991; 90: 36S–41S.

    Article  PubMed  CAS  Google Scholar 

  68. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med 1992; 85: 889–896.

    PubMed  CAS  Google Scholar 

  69. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. [Review]. Arch Intern Med 1989; 149: 1514–1520.

    Article  PubMed  CAS  Google Scholar 

  70. Donahue RP, Orchard TJ, Becker DJ, et al. Physical activity, insulin sensitivity, and the lipoprotein profile in young adults: the Beaver County Study. [Review]. Am J Epidemiol 1988; 127: 95–103.

    PubMed  CAS  Google Scholar 

  71. Thompson CJ, Ryu JE, Craven TE, et al. Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb 1991; 11: 327–333.

    Article  PubMed  CAS  Google Scholar 

  72. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 1991; 88: 609–613.

    Article  PubMed  CAS  Google Scholar 

  73. Larsson B, Bengtsson C, Bjorntorp P, et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 1992; 135: 266–273.

    PubMed  CAS  Google Scholar 

  74. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257–1261.

    Article  CAS  Google Scholar 

  75. Muscat JE, Harris RE, Haley NJ, et al. Cigarette smoking and plasma cholesterol. Am Heart J 1991; 121: 141–147.

    Article  PubMed  CAS  Google Scholar 

  76. Hellerstein MK, Benowitz NL, Neese RA, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994; 93: 265–272.

    Article  PubMed  CAS  Google Scholar 

  77. Facchini FS, Hollenbeck CB, Jeppesen J, et al. Insulin resistance and cigarette smoking [published erratum appears in Lancet 1992 Jun 13;339(8807):1492] [see comments]. Lancet 1992; 339: 1128–1130.

    Article  PubMed  CAS  Google Scholar 

  78. Axelsen M, Eliasson B, Joheim E, et al. Lipid intolerance in smokers [see comments]. J Intern Med 1995; 237: 449–455.

    Article  PubMed  CAS  Google Scholar 

  79. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2- isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198–1203.

    Article  PubMed  CAS  Google Scholar 

  80. McCully KS. Vascular pathology of homocysteinemia;implications for pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111–128.

    PubMed  CAS  Google Scholar 

  81. Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science 1964; 143: 1443–1445.

    Article  PubMed  CAS  Google Scholar 

  82. Rimm E, et al. Folate and Vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1997; 279: 359–364.

    Article  Google Scholar 

  83. Kannel WB, Hjortland MC, McNamara PM, et al. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447–452.

    PubMed  CAS  Google Scholar 

  84. Gordon T, Kannel WB, Hjortland MC, et al. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89: 157–161.

    PubMed  CAS  Google Scholar 

  85. Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–1110.

    Article  PubMed  CAS  Google Scholar 

  86. Gorodeski GI. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women. [Review]. Exp Gerontol 1994; 29: 357–375.

    Article  PubMed  CAS  Google Scholar 

  87. Downs J, Beere P, Whitney E, et al. Design and rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 1997; 80: 287–293.

    Article  PubMed  CAS  Google Scholar 

  88. Shepherd J, Cobbe SM, Ford I, et al. and the Group WoSCPS. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. N Engl J Med 1995; 333: 1301–1307.

    Article  PubMed  CAS  Google Scholar 

  89. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389.

    Google Scholar 

  90. Pfeffer M, Sacks F, Lemuel A, et al., for the CARE Investigators. Cholesterol and Recurrent Events: A Secondary Prevention Trial for Normolipidemic Patients. Am J Cardiol 1995; 76: 98–106.

    Article  Google Scholar 

  91. Tonkin A. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatian Survival Study (4S). Am J Cardiol 1995; 38: 107–112.

    Article  Google Scholar 

  92. Hussey S, Grady D, Bush T, et al., for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Post Menopausal Women. JAMA 1998; 280: 605–613.

    Google Scholar 

Download references

Authors
  1. JoAnne Micale Foody MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia Pordon DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Yale University School of Medicine, New Haven, CT, USA

    JoAnne Micale Foody MD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Foody, J.M., Pordon, C. (2001). Women and Coronary Artery Disease. In: Foody, J.M. (eds) Preventive Cardiology. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-001-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-001-8_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6241-9

  • Online ISBN: 978-1-59259-001-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation